Background illustration for clinical trials search

Paid Clinical Trials Portland

Discover 928 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

for
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases,
Location: Portland OR, Surrey, San Francisco CA, Calgary,
Sponsor: Eli Lilly and Company

Sex: All

Age: 6 - 17

Code: NCT05723198

Phase 3, Recruiting

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

for
Actinic Keratosis
Location: Portland OR, Burien WA, Spokane WA, Boise ID,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07144852

Phase 3, Recruiting

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

for
Actinic Keratosis
Location: Portland OR, Spokane WA, Fremont CA, New Brighton MN,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07144345

Phase 3, Recruiting

A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo

for
Vitiligo
Location: Portland OR, Fremont CA, Dallas TX, Hot Springs AR,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 18 - 70+

Code: NCT06625177

Phase 1, Recruiting

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

for
Alopecia Areata
Location: Portland OR, Spokane WA, Reno NV, Sacramento CA,
Sponsor: AbbVie

Sex: All

Age: 12 - 63

Code: NCT06012240

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Randomized Controlled Trial of Laparoscopic Gastric Bypass Plus Omentectomy Versus Laparoscopic Gastric Bypass Alone in Improving Diabetic Indices

for
Diabetes, Interleukins, Cytokines
Location: Portland OR
Sponsor: Legacy Health System

Sex: All

Age: 18+

Code: NCT00552942

Phase 3, Recruiting

OCT in Diagnosis of Irregular Corneas

for
Keratoconus, Corneal Opacity, Corneal Dystrophy
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 14 - 70+

Code: NCT03504800

Recruiting

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

for
Acute Respiratory Distress Syndrome, ARDS
Location: Portland OR, Boise ID, Davis CA, Sacramento CA,
Sponsor: Direct Biologics, LLC

Sex: All

Age: 18 - 70+

Code: NCT05354141

Phase 3, Recruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

for
Growth Hormone Deficiency
Location: Portland OR, Seattle WA, Boise ID, Sacramento CA,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 1 - 18

Code: NCT05775523

Recruiting

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

for
Migraine Disorders
Location: Portland OR, Springfield OR, La Jolla CA, Cincinnati OH,
Sponsor: Upsher-Smith Laboratories

Sex: All

Age: 6 - 11

Code: NCT04748601

Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

for
Stereotypical Prolonged Seizures
Location: Portland OR, Boise ID, Sacramento CA, Salt Lake City UT,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 12+

Code: NCT05077904

Phase 3, Recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Portland OR, Sacramento CA, Calgary, Palo Alto CA,
Sponsor: LEO Pharma

Sex: All

Age: 0 - 11

Code: NCT06311682

Phase 3, Recruiting

A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus

for
Lichen Sclerosus
Location: Portland OR, Fremont CA, Murray UT, Saskatoon,
Sponsor: LEO Pharma

Sex: All

Age: 18+

Code: NCT07335588

Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

for
Dystonia
Location: Portland OR, Kirkland WA, Spokane WA, Los Angeles CA,
Sponsor: Vima Therapeutics

Sex: All

Age: 18 - 70

Code: NCT07304089

Phase 2, Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for
Renal Cell Carcinoma (RCC),
Location: Portland OR, Las Vegas NV, Santa Barbara CA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase 1, Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

for
Non-obstructive Hypertrophic Cardiomyopathy
Location: Portland OR, San Francisco CA, Los Angeles CA,
Sponsor: Imbria Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07023614

Phase 2, Recruiting

A Study of PHN-012 in Patients With Advanced Solid Tumors

for
Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC),
Location: Portland OR, Los Angeles CA, San Diego CA,
Sponsor: Pheon Therapeutics

Sex: All

Age: 18+

Code: NCT07127874

Phase 1, Recruiting

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Portland OR, San Diego CA, Phoenix AZ, St Louis MO,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06974110

Phase 1, Recruiting

Observational Study of Corneal Opacities in Adults

for
Corneal Opacities (Scar and Stromal Dystrophy)
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18 - 70+

Code: NCT02109471

Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Portland OR, Puyallup WA, Tacoma WA, Redmond WA,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting